Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells

Oncogene

Volumn 31, Issue 2, 2012, Pages 149-160

  Bourguignon, L Y W ^a   Earle, C ^a   Wong, G ^a   Spevak, C C ^a   Krueger, K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD44; head neck cancer; hyaluronan; miR 21; nanog; Stat 3

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; INHIBITOR OF APOPTOSIS PROTEIN; MICRORNA 21; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR NANOG; TUMOR SUPPRESSOR PROTEIN;

ANTIGEN BINDING; ARTICLE; CHEMOSENSITIVITY; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; RNA ANALYSIS; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; HYALURONIC ACID; MICRORNAS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

INTRACISTERNAL A-PARTICLES;

EID: 84855781227     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.222     Document Type: Article

References (30)

1. Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S et al. (2008). Allgayer H. MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
2. Bourguignon LY. (2008). Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol 18: 251-259.
3. Bourguignon LY, Peyrollier K, Xia W, Gilad E. (2008). Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 283: 17635-17651.
4. Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. (2009a). Hyaluronan-CD44 interaction with PKCe promotes oncogenic signaling by the stem cell marker, Nanog and the production of microRNA-21 leading to downregulation of the tumor suppressor protein, PDCD4, anti-apoptosis and chemotherapy resistance in breast tumor cells. J Biol Chem 284: 26533-26546.
5. Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. (2010). Hyaluronan-CD44 interaction promotes c-Src-mediated Twist signaling, microRNA-10b expression and RhoA/RhoC upregulation leading to Rho-Kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem 285: 36721-36735.
6. Bourguignon LY, Xia W, Wong G. (2009b). Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem 284: 2657-2671.
7. Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C et al. (2008). MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123: 2791-2797.
8. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH. (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095.
9. Darnell Jr JE. (1997). STATs and gene regulation. Science 277: 1630-1635. (Pubitemid 27446219)
10. Ezeh UI, Turek PJ, Reijo RA, Clark AT. (2005). Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265. (Pubitemid 41579973)
11. Gyrd-Hansen M, Meier P. (2010). IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat Rev Cancer 10: 561-574.
12. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20. (Pubitemid 37046923)
13. Huang S. (2007). Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13: 1362-1366. (Pubitemid 46450423)
14. Hunter AM. (2007). The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568. (Pubitemid 47106887)
15. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
16. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ et al. (2009). Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18: 1093-1108.
17. Löffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermüller J, Kretzschmar AK et al. (2007). Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110: 1330-1333. (Pubitemid 47281433)
18. Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S et al. (2008). SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Res 68: 9384-9393.
19. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K et al. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642. (Pubitemid 36694188)
20. Nakamura M, Nakatani K, Uzawa K, Ono K, Uesugi H, Ogawara K. (2005). Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R. Oncol Rep 14: 1281-1286.
21. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. (Pubitemid 40372904)
22. Song JI, Grandis JR. (2000). STAT signaling in head and neck cancer. Oncogene 19: 2489-2495. (Pubitemid 30339204)
23. Toole BP, Hascall VC. (2002). Hyaluronan and tumor growth. Am J Pathol 161: 745-747. (Pubitemid 34988359)
24. Toole BP, Wight TN, Tammi MJ. (2002). Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277: 4593-4596. (Pubitemid 34968485)
25. Torre C, Wang SJ, Xia W, Bourguignon LY. (2010). Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling. Arch Otolaryngol Head Neck Surg 136: 493-501.
26. Turley EA, Noble PW, Bourguignon LY. (2002). Signaling properties of hyaluronan receptors. J Biol Chem 277: 4589-4592. (Pubitemid 34968484)
27. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
28. Wang S, Bourguignon LY. (2011). Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol 178: 956-963.
29. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 119: 1518-1530.
30. Wen Z, Zhong Z, Darnell Jr JE. (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250.